LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
LeMaitre Vascular (Nasdaq:LMAT) will release fourth-quarter 2025 financial results on February 25, 2026 after the market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) will release fourth-quarter 2025 financial results on February 25, 2026 after the market close. A conference call is scheduled the same day at 5:00 PM EST to review results, business highlights, and company outlook. The live audio webcast and replay will be available at the company investor website, and registrants receive dial-in details and a PIN.
Details
News Market Reaction – LMAT
On Feb 11, the day this news came out, LMAT closed 0.23% below the previous close.
Data tracked by StockTitan Argus for the Feb 11 session.
Key Figures
- Q3 2025 sales
- $61.0mm
- Reported Nov 6, 2025
- Q3 2025 GAAP operating income
- $20.3mm
- Up 54% year-over-year
- Q3 2025 diluted EPS
- $0.75
- Up 54% year-over-year
- Adjusted gross margin
- 70.8%
- Q3 2025, up 300 bps
- Quarterly dividend
- $0.20/share
- Declared for payment Dec 4, 2025
- Share repurchase authorization
- $75.0mm
- Program through Feb 17, 2026
- FY 2025 mid sales guidance
- $248mm
- Implied +13% growth
- Conestoga ownership
- 6.73%
- 1,527,429 shares as of 12/31/2025
Historical Context
-
Q3 2025 beat-style metrics with raised full-year 2025 guidance.
-
Announcement of Q3 2025 release timing and conference call details.
-
Participation in multiple late-2025 investor healthcare conferences.
-
September 2025 conference schedule with several major brokers.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at www.lemaitre.com/investor.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. + 1-781-362-1260 gmanker@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.